Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (101-110 of 466) with videos related to

Pageof 47
Sort By:
The Journal of Infectious Diseases|November 27, 2020
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the ClinicSahar Bajis, Tanya L Applegate, Jason Grebely, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysisIan Lockart, Malcolm G H Yeo, Behzad Hajarizadeh, et al.
Lancet (London, England)|September 12, 2006
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage studyJanaki Amin, Matthew G Law, Mark Bartlett, et al.
The Medical Journal of Australia|September 16, 2014
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c studyBethany White, Gregory J Dore, Andrew R Lloyd, et al.
The International Journal on Drug Policy|August 10, 2015
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
Australian and New Zealand Journal of Public Health|January 16, 2004
Late HIV presentation among AIDS cases in Australia, 1992-2001Ann M McDonald, Yueming Li, Gregory J Dore, et al.
The International Journal on Drug Policy|August 10, 2015
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2019
Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinomaSichan He, Ian Lockart, Maryam Alavi, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
Pageof 47

Showing results (101-110 of 466) with videos related to

Sort By:
Pageof 47
The Journal of Infectious Diseases|November 27, 2020
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the ClinicSahar Bajis, Tanya L Applegate, Jason Grebely, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysisIan Lockart, Malcolm G H Yeo, Behzad Hajarizadeh, et al.
Lancet (London, England)|September 12, 2006
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage studyJanaki Amin, Matthew G Law, Mark Bartlett, et al.
The Medical Journal of Australia|September 16, 2014
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c studyBethany White, Gregory J Dore, Andrew R Lloyd, et al.
The International Journal on Drug Policy|August 10, 2015
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
Australian and New Zealand Journal of Public Health|January 16, 2004
Late HIV presentation among AIDS cases in Australia, 1992-2001Ann M McDonald, Yueming Li, Gregory J Dore, et al.
The International Journal on Drug Policy|August 10, 2015
Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugsJason Grebely, Philip Bruggmann, Carla Treloar, et al.
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2019
Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinomaSichan He, Ian Lockart, Maryam Alavi, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
Pageof 47